BBC0403
Product Specifications
UNSPSC Description
BBC0403 is a selective BRD2 inhibitor with Kds of 7.64 μM and 41.37 μM for BRD2 (BD2) and BRD2 (BD1), respectively. BBC0403 exhibitS higher binding specificity for BRD2 compared to BRD3 and BRD4. BBC0403 has the potential for osteoarthritis (OA) research[1].
Target Antigen
Epigenetic Reader Domain
Type
Reference compound
Related Pathways
Epigenetics
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/bbc0403.html
Solubility
DMSO : 25 mg/mL (ultrasonic;warming;heat to 60°C)
Smiles
O=C1NC(C2=CC(C)=C(OC3COC3)C(C)=C2)=NC4=C1C(OC)=CC(OC)=C4
Molecular Weight
382.41
References & Citations
[1]Hyemi Lee, et al. BRD2-specific inhibitor, BBC0403, inhibits the progression of osteoarthritis pathogenesis in osteoarthritis-induced C57BL/6 male mice. Br J Pharmacol. 2024 Apr 10.
Shipping Conditions
Room Temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-162514/BBC0403-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-162514/BBC0403-SDS-MedChemExpress.pdf
Clinical Information
No Development Reported
CAS Number
2644662-83-7
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS7009766-01 0.02 mg
Recombinant Prochlorococcus marinus ATP synthase subunit b (atpF)
Ask
View Details MBS7009766-02 0.1 mg
Recombinant Prochlorococcus marinus ATP synthase subunit b (atpF)
Ask
View Details 
MBS7009766-03 5x 0.1 mg
Recombinant Prochlorococcus marinus ATP synthase subunit b (atpF)
Ask
View Details